| Neuland Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524558 |
NSE Symbol : NEULANDLAB |
P/E(TTM) : 50.35 |
|
ISIN Demat : INE794A01010 |
Div & Yield% : 0.11 |
EPS(TTM) : 249.53 |
|
Book Value(₹) : 994.26 |
Market Cap(₹Cr) : 16,120.50 |
Face Value(₹) : 10.00 |
| Particulars | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | 1,558.58 | 1,191.20 | 951.08 | 936.91 | 762.71 |
| Excise Duty | - | - | - | - | - |
| Net Sales | 1,558.58 | 1,191.20 | 951.08 | 936.91 | 762.71 |
| Other Income | 12.54 | 9.75 | 2.08 | 16.09 | 3.89 |
| Stock Adjustments | 55.14 | 9.51 | 15.41 | 1.24 | 11.16 |
| Total Income | 1,626.26 | 1,210.46 | 968.57 | 954.24 | 777.76 |
| EXPENDITURE : | |||||
| Raw Materials | 636.49 | 491.98 | 441.79 | 443.04 | 394.41 |
| Power and Fuel Cost | 48.72 | 48.62 | 42.21 | 39.21 | 32.75 |
| Other Manufacturing Expenses | 103.73 | 82.69 | 84.92 | 73.71 | 61.79 |
| Selling and Administration Expenses | 104.29 | 88.50 | 70.50 | 79.80 | 51.76 |
| Miscellaneous Expenses | 10.04 | 22.77 | 9.12 | 11.93 | 13.21 |
| Employee Benefit Expenses | 248.53 | 194.84 | 175.76 | 144.02 | 118.48 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 474.47 | 281.06 | 144.27 | 162.54 | 105.34 |
| Interest | 14.00 | 13.07 | 13.49 | 17.90 | 21.57 |
| Gross Profit | 460.47 | 267.99 | 130.78 | 144.64 | 83.77 |
| Depreciation | 59.70 | 52.78 | 49.04 | 39.68 | 31.28 |
| Profit Before Tax | 400.77 | 215.21 | 81.74 | 104.96 | 52.49 |
| Current Tax | 99.59 | 50.39 | 20.42 | 12.48 | - |
| Fringe Benefit tax | - | - | - | - | - |
| Deferred Tax | 1.59 | 1.70 | -2.22 | 12.18 | 36.62 |
| Reported Net Profit | 299.60 | 163.12 | 63.53 | 80.29 | 15.88 |
| Extraordinary Items | -0.30 | -0.66 | -1.36 | 9.81 | 0.12 |
| Adjusted Net Profit | 299.90 | 163.78 | 64.89 | 70.48 | 15.76 |
| Adjustment below Net Profit | - | - | - | - | -0.18 |
| Profit/Loss Balance carried down | 460.54 | 303.84 | 244.15 | 166.42 | 155.67 |
| Statutory Appropriations | - | - | - | - | - |
| Appropriations | 12.83 | 6.41 | 3.85 | 2.57 | 4.95 |
| P & L Balance carried down | 747.31 | 460.54 | 303.84 | 244.15 | 166.42 |
| Dividend | - | - | - | - | - |
| Preference Dividend | - | - | - | - | - |
| Equity Dividend (%) | 140.00 | 100.00 | 50.00 | 50.00 | 20.00 |
| Dividend Per Share(Rs) | 14.00 | 10.00 | 5.00 | 5.00 | 2.00 |
| Earnings Per Share-Unit Curr | 232.24 | 126.44 | 49.25 | 62.24 | 12.31 |
| Earnings Per Share(Adj)-Unit Curr | 232.24 | 126.44 | 49.25 | 62.24 | 12.31 |
| Book Value | 988.88 | 765.49 | 647.06 | 605.44 | 546.26 |
| Book Value(Adj)-Unit Curr | 988.88 | 765.49 | 647.06 | 605.44 | 546.26 |